Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Berg

Showing results (351-360 of 547) with videos related to

Pageof 55
Sort By:
Frontiers in Psychology|September 25, 2023
Older adults' coping strategies during the COVID-19 pandemic - a longitudinal mixed-methods studyLydia Kastner, Ulrike Suenkel, Gerhard W Eschweiler, et al.
Journal of Neuropsychology|October 16, 2018
Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patientsSara Becker, Alena Bäumer, Walter Maetzler, et al.
European Journal of Neurology|November 1, 2021
Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's diseaseEva Schaeffer, Benjamin Roeben, Oliver Granert, et al.
Neuro-Degenerative Diseases|April 26, 2017
Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: Differences between Cognitive SubtypesBernhard Cerff, Walter Maetzler, Patricia Sulzer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2016
Validation of conversion between mini-mental state examination and montreal cognitive assessmentMichael Lawton, Meike Kasten, Margaret T May, et al.
Behavioural Brain Research|April 21, 2012
6-Hydroxydopamine leads to T2 hyperintensity, decreased claudin-3 immunoreactivity and altered aquaporin 4 expression in the striatumBritta Wachter, Sonja Schürger, Andreas Schmid, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 19, 2014
The relation of SMI and the VSEP in a risk sample for neurodegenerative disordersKatja Hagen, Ann-Christine Ehlis, Florian B Haeussinger, et al.
Frontiers in Aging Neuroscience|March 21, 2018
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's DiseaseDaniel Stoessel, Claudia Schulte, Marcia C Teixeira Dos Santos, et al.
Neuropsychology|March 20, 2020
Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patientsSara Becker, Alena Bäumer, Walter Maetzler, et al.
International Journal of Molecular Sciences|October 27, 2022
A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest RiskMichal Becker-Cohen, Ari Zimran, Tama Dinur, et al.
Pageof 55

Showing results (351-360 of 547) with videos related to

Sort By:
Pageof 55
Frontiers in Psychology|September 25, 2023
Older adults' coping strategies during the COVID-19 pandemic - a longitudinal mixed-methods studyLydia Kastner, Ulrike Suenkel, Gerhard W Eschweiler, et al.
Journal of Neuropsychology|October 16, 2018
Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patientsSara Becker, Alena Bäumer, Walter Maetzler, et al.
European Journal of Neurology|November 1, 2021
Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's diseaseEva Schaeffer, Benjamin Roeben, Oliver Granert, et al.
Neuro-Degenerative Diseases|April 26, 2017
Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: Differences between Cognitive SubtypesBernhard Cerff, Walter Maetzler, Patricia Sulzer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2016
Validation of conversion between mini-mental state examination and montreal cognitive assessmentMichael Lawton, Meike Kasten, Margaret T May, et al.
Behavioural Brain Research|April 21, 2012
6-Hydroxydopamine leads to T2 hyperintensity, decreased claudin-3 immunoreactivity and altered aquaporin 4 expression in the striatumBritta Wachter, Sonja Schürger, Andreas Schmid, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 19, 2014
The relation of SMI and the VSEP in a risk sample for neurodegenerative disordersKatja Hagen, Ann-Christine Ehlis, Florian B Haeussinger, et al.
Frontiers in Aging Neuroscience|March 21, 2018
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's DiseaseDaniel Stoessel, Claudia Schulte, Marcia C Teixeira Dos Santos, et al.
Neuropsychology|March 20, 2020
Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patientsSara Becker, Alena Bäumer, Walter Maetzler, et al.
International Journal of Molecular Sciences|October 27, 2022
A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest RiskMichal Becker-Cohen, Ari Zimran, Tama Dinur, et al.
Pageof 55